Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder-MedSci.cn

Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder

Kadouh, NK; Lang, S; Shamoun, M; Scott, EL; Singh, SA; Smith, MA

Smith, MA (通讯作者)，Univ Michigan, Coll Pharm, Dept Clin Pharm, Adult Palliat Care, F7870 UH South,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.

PEDIATRIC BLOOD & CANCER, 2022; 69 (8):

科室
- - 订阅+
  - 更多科室
工具
服务